What BioPharm Communications does

BioPharm Communications, LLC is a private healthcare marketing company headquartered in New Hope, Pennsylvania, that develops and deploys proprietary multichannel marketing programs for pharmaceutical brands seeking to educate healthcare professionals (HCPs). The company operates a precision marketing platform called 'tandem' that powers three core solutions: Always ON/MD (an always-on network of more than 3 million healthcare decision makers), Moments (trigger-based next-best-action targeting), and Peer-Based Deep Education (KOL-validated scientific programs). The platform incorporates AI-powered KOL avatar video generation, partnerships with 150+ medical journals, and multichannel distribution across paid social, display, email, and direct mail, with performance metrics claiming 100% active match rates across channels.

The company's customer base consists of 16 named enterprise pharmaceutical clients including Novartis, Takeda, Janssen, Novo Nordisk, Merck, AstraZeneca, Bristol Myers Squibb, Amgen, Bayer, Daiichi Sankyo, and Eisai, with the firm reporting 521 client campaigns executed since 2021 and an 8.8% average prescription lift for client programs. BioPharm operates a B2B enterprise field sales motion targeting brand teams, medical affairs, and marketing departments at pharmaceutical companies; pricing is not publicly disclosed and follows a quote-based professional services model typical of healthcare marketing agencies.

The firm employs 101-250 people and has operated for approximately two decades in healthcare marketing. Reported performance metrics include 100% active match rates across channels, 85% match rates for targeted display and email, 50% match rates for paid social, ~1 million HCPs reached, 94 million+ campaign exposures, and 2.8 million+ engagements recorded. The company is privately held as an LLC with one recorded funding event (2012, Ingleside Investors, undisclosed amount), and operates without disclosed parent entity, institutional investors, or public listing.

Name

BioPharm Communications

Legal name

BioPharm Communications, LLC

Website

https://biopharmcommunications.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

BioPharm Communications is a private B2B healthcare marketing company that operates the tandem precision marketing platform and a 3M+ healthcare decision-maker network to deliver multichannel HCP education campaigns for enterprise pharmaceutical brands.

Ownership category

akta.pro rank

Product category

Healthcare Marketing Services

NAICS

Educational Support Services (61171)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Healthcare professional marketing
• Pharmaceutical marketing services
• KOL engagement programs
• HCP multichannel campaigns
• Medical education marketing

Headquarters

HQ city

New Hope

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Healthcare Professional Marketing Services: BioPharm Communications provides marketing and education services to pharmaceutical brands to reach and educate healthcare professionals. The company likely operates on a project-based or retainer fee model typical of healthcare marketing agencies, though specific revenue mechanics are not explicitly disclosed.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

BioPharm Communications develops and deploys proprietary multichannel HCP education and brand marketing programs for pharmaceutical clients through its tandem precision marketing engine. Core offerings include an always-on network of 3M+ healthcare decision makers (Always ON/MD), trigger-based activation (Moments), and KOL-validated peer-based scientific deep education, supported by AI-powered KOL avatar video technology and integrated measurement and optimization services.

Product overview

BioPharm Communications offers a unified precision marketing platform called tandem that connects pharmaceutical brands with healthcare professionals (HCPs) through three core solutions: Always ON/MD (always-on network of 3M+ HCDMs), Moments (trigger-based next best actions), and Deep Education (KOL-validated scientific programs). The platform also includes KOL-focused sub-products such as KOL Insights, KOL-led Patient Cases, Expert Perspectives Sponsorship, and Live KOL Video Development. AI-powered KOL avatars enable scalable video-first education. The Measurement & Optimization service provides campaign performance transparency with ROI tracking.

Differentiator

Problem solved

Functional benefit

Products and services

• tandem Precision Marketing Engine Best-in-class precision marketing platform that enables data-driven activation and executes BioPharm's healthcare professional engagement solutions across multiple channels for pharmaceutical brand clients.
• Always ON / MD Always-on network engagement program that drives reach, frequency, and engagement with more than 3M healthcare decision makers through a templated, modular content approach, delivering market-ready iterations in less than 3 weeks for pharmaceutical brand teams.
• Moments Trigger-based next-best-action activation program that leverages proprietary data and activation capabilities to deliver relevant messaging at key HCP engagement moments, designed to impact prescription decisions and change behavior.
• Peer-Based Deep Education Science-rooted peer-based education programs created with and validated by Key Opinion Leaders, designed to educate healthcare professionals through KOL Insights, KOL-led Patient Cases, Expert Perspectives multichannel advertising, and Live KOL Video Development formats.
• AI Avatar Video Education AI-powered KOL-based avatars that enable HCP education through video content generated from scripts in minutes, with message evolution based on user experience and translation capabilities for global markets.
• Measurement & Optimization Measurement and optimization service providing consistent metrics reports, in-campaign performance-based optimizations, NPI-level reporting, ongoing data transfers, BOT trapping and filtering, and an automated ROI tool for pharmaceutical brand clients.

Quantifiable outcome

• 8.8% average prescription lift for client campaigns (calculated as increase in average scrips per target relative to control group)
• +4 more outcomes

Named customers16 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

One partnership is on record.

• Medical Journal Partners (150+ journals)coreStrategic or Co-development PartnerPartnerships with over 150 medical journals (print and electronic) enable access to peer-reviewed medical content and credible scientific platforms for delivering HCP education on behalf of pharmaceutical clients. These partnerships are integral to the 'Peer-Based Deep Education' and 'Expert Perspectives' solution offerings.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Publicis Health: Publicis Health is the healthcare arm of Publicis Groupe, offering creative, media, and medical communications services to pharma. It is a portfolio competitor to BioPharm's agency work and global pharma brand engagements rather than a platform peer.
• IQVIA: IQVIA is the largest global healthcare commercial services and data company, including significant pharma marketing, HCP promotion, and real-world evidence analytics. It competes with BioPharm at the enterprise pharma brand level across campaigns, measurement, and KOL activation but across a vastly broader portfolio.
• Omnicom Health Group: Omnicom Health Group is a network of healthcare-focused agencies (DDB Health, CDM, TBWA\WorldHealth) serving global pharma brand marketing. It competes for the same pharma enterprise clients as BioPharm Communications but across a broader agency-style service offering.

Direct peers

• PatientPoint: PatientPoint runs a multichannel HCP and patient engagement network (point-of-care, digital, and physician-office programs) funded by pharma brand sponsorships. It mirrors BioPharm's always-on, multichannel, outcomes-measured model for engaging HCPs at decision moments.
• Doximity: Doximity operates the largest U.S. HCP networking platform (~2M verified members) and sells targeted promotional and content solutions to pharma brands. It is the closest comparable to BioPharm's Always ON/MD network plus promotion model, with similar product surfaces (newsfeed, content, KOL video).
• Strategic Communications / Closerlook: closerlook is a healthcare marketing agency focused on HCP and patient engagement for pharma brands, with data-driven activation and omnichannel campaigns. It is a similarly sized specialty agency peer of BioPharm's enterprise field-sales motion.
• WebMD Medscape: Medscape is the leading global medical education and HCP media platform (owned by WebMD/Internet Brands) with deep education, KOL content, and pharma sponsorship offerings. It directly overlaps BioPharm's Deep Education, KOL Insights, and medical journal-adjacent content businesses.

Others

• Veeva Systems: Veeva provides the dominant CRM, content, and data cloud used by pharma commercial teams (Veeva Vault, Veeva CRM). It is an enabling technology competitor/partner rather than a direct marketing services peer, but represents the platform-level alternative BioPharm's tandem engine competes against inside the same enterprise workflows.
• H1 (now Definitive Healthcare): Definitive Healthcare aggregates HCP, institution, and account-level data used by pharma commercial teams to target and measure marketing. It is an enabling data/analytics infrastructure layer rather than a direct competitor, but overlaps with BioPharm's data and targeting capabilities.

Emerging players

• Sermo: Sermo operates a global physician community and HCP insights/marketing platform used by pharma for KOL engagement and market research. It overlaps BioPharm's KOL Insights and Moments solutions but is smaller and more research-oriented than a full always-on marketing engine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/biopharmcommunications
• Xx.com/BioPharmComm
• LinkedInlinkedin.com/company/biopharm-communications

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioPharm Communications